Podcasts

A psychiatrist and psychiatric nurse practitioner discuss collaboration and patient support.

Explore GLP-1 agonists and their "truly transformative" role in psychiatry in this podcast.

Learn more about the treatment of depression, selective serotonin reuptake inhibitors, and pregnancy in this podcast.

Dissect psychodermatology with experts in both fields, from the American Academy of Dermatology 2026.

Explore how depression, anxiety, diet, and social factors shape heart disease—and why cardiology and psychiatry must team up for better care.

Psychiatry experts unpack why off-label medications are common and how evidence and dosing guide care.

Experts unpack bereavement’s hidden health and economic toll.

Experts discuss why early treatment and tailored combos can curb bipolar disorder.

Experts unpack child psychiatric medication: safety, early intervention, suicide risk, and managing side effects.

Explore the complexities of psychopharmacology in treating personality disorders, focusing on symptom management and the importance of therapeutic alliances.

Explore how Shambrekia Wise's "Sightseeing with Sandy" series promotes cultural humility and empathy in children through global travel and shared experiences.

Explore the complexities of pharmacogenetic testing in psychiatry, uncovering its current limitations and future potential in personalized medicine.

Explore the transformative power of vulnerability in mental health and human connection with insights from Manizeh Mirza-Gruber, MD, and Frank Clark, MD.

Learn more about the transformative potential of psychedelics in treating depression and mood disorders through expert insights and groundbreaking research.

Explore the intersection of psychotherapy and pharmacology in treating mood disorders, emphasizing personalized approaches for optimal patient outcomes.

What is the role of GLP-1 agonists in psychiatry? Joseph F. Goldberg, MD, and Roger S. McIntyre, MD, FRCPC, share their thoughts.

In this podcast, Psychiatric Times editor-in-chief Dr. John J. Miller interviews Dr. Stephen Faraone, distinguished professor and vice chair of research of psychiatry and behavioral sciences at Upstate Medical University in Syracuse, New York, about the evolving world of nonpharmacologic interventions for ADHD, in particular digital therapeutics.

Research is underway to make psychedelics agents a treatment option for psychiatric disorders.

Scare tactics don’t work. But scientific education might. Here are tips for talking with teenaged patients about keeping themselves and their friends safe.

How to regulate circadian rhythms and regulate mood using dark therapy.

Forensic psychiatry is not for everyone, but looking back on his life and illustrious career, James L. Knoll IV, MD, realizes that he was destined to study crime.

James L. Knoll IV, MD, shares insights from his decades in forensic psychiatry, where he has treated some of the criminal justice system’s most difficult and dangerous patients.

What can Olympians teach mental health professionals about caring for student athletes—and others too?

Blue light is associated with a host of physical health maladies, including obesity, diabetes, and cancer. But what does it do to patients with depression or bipolar disorder?

A deep dive into the history, side effects, and efficacy of a controversial drug.

Although the new drug aducanumab has grabbed all the headlines, the future of Alzheimer treatment may be just as much about public health campaigns as it is about psychopharmacology. In this episode of Psych Pearls, we find out why.

Although depression is more prevalent among women, it may be more challenging to diagnose in men. This National Men’s Health Month, learn to recognize male depression’s symptoms and catch its comorbidities.

In the early days of the COVID-19 pandemic, physicians were thrust into unfamiliar roles, where they sometimes had to make life and death decisions. Here are a few of their stories.